Analyst Ratings for Haemonetics (HAE)

HAE Rating Summary

HAE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on HAE
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $79.38 (+20.5%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/22/2026 BofA Securities Craig Bijou Upgrade Buy
(Neutral)
80.00
(72.00)
61.94
(65.88)
6.36% Details
12/15/2025 Needham Mike Matson Downgrade Hold
(Buy)
N/A
(N/A)
83.49
(65.88)
-21.09% Details